Factors Influencing Perioperative Blood Transfusions in Patients with Gastrointestinal Cancer

Journal of Surgical Research

Volumn 141, Issue 1, 2007, Pages 97-104

  Verma, Varun ^a   Schwarz, Roderich E ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

bold transfusions; gastrectomy; gastrointestinal cancer; liver resection; pancreatectomy

Indexed keywords

ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD TRANSFUSION; CLINICAL PRACTICE; DIGESTIVE SYSTEM CANCER; FEMALE; GASTROINTESTINAL SURGERY; HUMAN; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS SURGERY; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD CELL COUNT; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ERYTHROPOIETIN; FEMALE; GASTROINTESTINAL NEOPLASMS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 34250157398     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.03.032     Document Type: Article

References (50)

1. Fong Y., Karpeh M., Mayer K., et al. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 167 (1994) 256
2. Craig S.R., Adam D.J., Yap P.L., et al. Effect of blood transfusion on survival after esophagogastrectomy for carcinoma. Ann Thorac Surg 66 (1998) 356
3. Jarnagin W.R., Gonen M., Fong Y., et al. L. H. Improvement in perioperative outcome after hepatic resection: Analysis of 1803 consecutive cases over the past decade. Ann Surg 236 (2002) 397 Discussion 406
4. Park S.J., Kim S.W., Jang J.Y., et al. Intraoperative transfusion: Is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy?. World J Surg 26 (2002) 487
5. Benoist S., Panis Y., Pannegeon V., et al. Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients. Surgery 129 (2001) 433
6. Poon R.T., Fan S.T., Lo C.M., et al. J. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: Analysis of 1222 consecutive patients from a prospective database. Ann Surg 240 (2004) 698 Discussion 708
7. Dellinger E.P., and Anaya D.A. Infectious and immunological consequences of blood transfusion. Crit Care 2 Suppl (2004) S18
8. Kooby D.A., Stockman J., Ben-Porat L., et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 860 Discussion 869
9. Dunne J.R., Malone D., Tracy J.K., et al. Perioperative anemia: An independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 102 (2002) 237
10. Dresner S.M., Lamb P.J., Shenfine J., et al. Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 26 (2000) 492
11. Dhar D.K., Kubota H., Tachibana M., et al. A tailored perioperative blood transfusion might avoid undue recurrences in gastric carcinoma patients. Dig Dis Sci 45 (2000) 1737
12. Cameron J.L., Crist D.W., Sitzmann J.V., et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161 (1991) 120 Discussion 124
13. Pedrazzoli S., DiCarlo V., Dionigi R., et al., Lymphadenectomy Study Group. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Ann Surg 228 (1998) 508
14. van de Watering L.M., Brand A., Houbiers J.G., et al. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg 88 (2001) 267
15. Braga M., Gianotti L., Gentilini O., et al. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery. Hepatogastroenterology 44 (1997) 685
16. Levine E.A., Laborde C., Hambrick E., et al. Influence of erythropoietin on transfusion requirements in patients receiving preoperative chemoradiotherapy for rectal cancer. Dis Colon Rectum 42 (1999) 1065 Discussion 1069
17. Kosmadakis N., Messaris E., Maris A., et al. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: Prospective randomized double-blind study. Ann Surg 237 (2003) 417
18. Christodoulakis M., and Tsiftsis D.D. Preoperative epoetin α in colorectal surgery: A randomized, controlled study. Ann Surg Oncol 12 (2005) 718
19. Heiss M.M., Tarabichi A., Delanoff C., et al. Perisurgical erythropoietin application in anemic patients with colorectal cancer: A double-blind randomized study. Surgery 119 (1996) 523
20. Dousias V., Stefos T., Navrozoglou I., et al. Administration of recombinant human erythropoietin in patients with gynecological cancer before radical surgery. Clin Exp Obstet Gynecol 32 (2005) 129
21. Gaston K.E., Kouba E., Moore D.T., et al. The use of erythropoietin in patients undergoing radical prostatectomy: Effects on hematocrit, transfusion rates, and quality of life. Urol Int 77 (2006) 211
22. Kettelhack C., Hones C., Messinger D., et al. Randomized multicenter trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 85 (1998) 63
23. Braga M., Gianotti L., Vignali A., et al. Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract. Br J Surg 82 (1995) 1637
24. Dindo D., Demartines N., and Clavien P.A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004) 205
25. Schwarz R.E., Karpeh M.S., and Brennan M.F. Factors predicting hospitalization after operative treatment for gastric carcinoma in patients older than 70 years. [see comments]. J Am Coll Surg 184 (1997) 9
26. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective, randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 (2005) 618 Discussion 628
27. Schmidt C.M., Powell E.S., Yiannoutsos C.T., et al. Pancreaticoduodenectomy: A 20-year experience in 516 patients. Arch Surg 139 (2004) 718 Discussion 725
28. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, Part 2: Randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 (2002) 355 Discussion 366
29. Lodge J.P., Jonas S., Oussoultzoglou E., et al. Recombinant coagulation factor VIIa in major liver resection: A randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 102 (2005) 269
30. Itamoto T., Katayama K., Nakahara H., et al. Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease. Br J Surg 90 (2003) 23
31. Murata N., Idezuki Y., Konishi T., et al. Influence of perioperative blood transfusion on the prognosis of patients with gastric cancer receiving anticancer chemotherapy. Gastric Cancer 3 (2000) 24
32. Matsumata T., Itasaka H., Shirabe K., et al. Strategies for reducing blood transfusions in hepatic resection. HPB Surg 8 (1994) 1 Discussion 6
33. Benzoni E., Lorenzin D., Baccarani U., et al. Resective surgery for liver tumor: a multivariate analysis of causes and risk factors linked to postoperative complications. Hepatobiliary Pancreat Dis Int 5 (2006) 526
34. Rovera F., Dionigi G., Boni L., et al. Postoperative infections after oesophageal resections: The role of blood transfusions. World J Surg Oncol 4 (2006) 80
35. Werther K., Christensen I.J., and Nielsen H.J. The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer. Eur J Surg 167 (2001) 287
36. Geer R.J., and Brennan M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165 (1993) 68 Discussion 72
37. Donohue J.H., Williams S., Cha S., et al. Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: A Mayo/North Central Cancer Treatment Group study. J Clin Oncol 13 (1995) 1671
38. Heiss M.M., Allgayer H., Gruetzner K.U., et al. Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients. Anticancer Res 17 (1997) 2657
39. Shen J.G., Cheong J.H., Hyung W.J., et al. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer. J Surg Oncol 91 (2005) 126
40. Schwarz R.E., Harrison L.E., Conlon K.C., et al. The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma. J Am Coll Surg 188 (1999) 516
41. Weitz J., D'Angelica M., Gonen M., et al. Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. J Clin Oncol 21 (2003) 4597
42. Shen J.G., Cheong J.H., Hyung W.J., et al. Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. Am J Surg 192 (2006) 301
43. Melendez J.A., Arslan V., Fischer M.E., et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: Blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 187 (1998) 620
44. Smith D.L., Arens J.F., Barnett Jr. C.C., et al. A prospective evaluation of ultrasound-directed transparenchymal vascular control with linear cutting staplers in major hepatic resections. Am J Surg 190 (2005) 23
45. Dougenis D., Patrinou V., Filos K.S., et al. Blood use in lung resection for carcinoma: Perioperative elective anaemia does not compromise the early outcome. Eur J Cardiothorac Surg 20 (2001) 372
46. Chan A.C., Blumgart L.H., Wuest D.L., et al. Use of preoperative autologous blood donation in liver resections for colorectal metastases. Am J Surg 175 (1998) 461
47. Jabbour N., Gagandeep S., Shah H., et al. Impact of a transfusion-free program on non-Jehovah's Witness patients undergoing liver transplantation. Arch Surg 141 (2006) 913
48. Martin R.C., Wellhausen S.R., Moehle D.A., et al. Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol 12 (2005) 1017
49. Paul I., Lappin T.R., Maxwell P., et al. Preoperative plasma erythropoietin concentration and survival following surgery for non-small cell lung cancer. Lung Cancer 51 (2006) 329
50. Dunphy F.R., Harrison B.R., Dunleavy T.L., et al. Erythropoietin reduces anemia and transfusions: A randomized trial with or without erythropoietin during chemotherapy. Cancer 86 (1999) 1362